RPTX Company Profile and Key Details
Repare Therapeutics Inc.
RPTX Stock Price Chart
Stock Price Today
Repare Therapeutics Inc. (RPTX) stock declined over -4.04%, trading at $1.16 on NASDAQ, down from the previous close of $1.21. The stock opened at $1.20, fluctuating between $1.16 and $1.22 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
Company Information
| Employees | 179 |
| Beta | 0.71 |
| Sales or Revenue | $51.13M |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Repare Therapeutics Inc. (NASDAQ: RPTX) stock price is $1.16 in the last trading session. During the trading session, RPTX stock reached the peak price of $1.22 while $1.16 was the lowest point it dropped to. The percentage change in RPTX stock occurred in the recent session was -4.04% while the dollar amount for the price change in RPTX stock was -$0.05.
The NASDAQ listed RPTX is part of Biotechnology industry that operates in the broader Healthcare sector. Repare Therapeutics Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Frank Sicheri Ph.D.
Co-Founder
Dr. Daniel Durocher Ph.D.
Co-Founder
Dr. Michael Zinda Ph.D.
Executive Vice President & Chief Scientific Officer
Mr. Cameron Black
Executive Vice President of Discovery
Mr. Philip Herman
Executive Vice President, Chief Commercial & Portfolio Devel. Officer
Dr. Kim A. Seth Ph.D.
Executive Vice President & Chief Bus. Officer
Mr. Steve Forte
Executive Vice President & Chief Financial Officer
Dr. Agnel Sfeir Ph.D.
Co-Founder
Mr. Daniel Belanger
Executive Vice President of Human Resource
Dr. Maria Koehler M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Mr. Lloyd Mitchell Segal
Pres, Chief Executive Officer & Director
RPTX's closing price is 0.83% higher than its 52-week low of $1.16 where as its distance from 52-week high of $8.49 is -85.75%.
Number of RPTX employees currently stands at 179.
Official Website of RPTX is: https://www.reparerx.com
RPTX could be contacted at phone 857 412 7018 and can also be accessed through its website. RPTX operates from 7210 Frederick-Banting, Montreal, QC H4S 2A1, Canada.
RPTX stock volume for the day was 94.47K shares. The average number of RPTX shares traded daily for last 3 months was 432.97K.
The market value of RPTX currently stands at $49.36M with its latest stock price at $1.16 and 42.51M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com